PLoS ONE (Jan 2023)

Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.

  • Dianna Wolfe,
  • Kim Corace,
  • Claire Butler,
  • Danielle Rice,
  • Becky Skidmore,
  • Yashila Patel,
  • Premika Thayaparan,
  • Alan Michaud,
  • Candyce Hamel,
  • Andra Smith,
  • Gary Garber,
  • Amy Porath,
  • David Conn,
  • Melanie Willows,
  • Hanan Abramovici,
  • Kednapa Thavorn,
  • Salmaan Kanji,
  • Brian Hutton

DOI
https://doi.org/10.1371/journal.pone.0281826
Journal volume & issue
Vol. 18, no. 2
p. e0281826

Abstract

Read online

BackgroundCannabis legalization has enabled increased consumption in older adults. Age-related mental, physical, and physiological changes may lead to differences in effects of cannabis in older adults compared to younger individuals.ObjectiveTo perform a scoping review to map the evidence regarding the health effects of cannabis use for medical and non-medical purposes in older adults.MethodsElectronic databases (MEDLINE, Embase, PsycINFO, Cochrane Library) were searched for systematic reviews (SRs), randomized controlled trials (RCTs) and non-randomized/observational studies (NRSs) assessing the health effects and associations of cannabis use (medical or non-medical) in adults ≥ 50 years of age. Included studies met age-related inclusion criteria or involved a priori identified health conditions common among older adults. Records were screened using a liberal accelerated approach and data charting was performed independently by two reviewers. Descriptive summaries, structured tables, effect direction plots and bubble plots were used to synthesize study findings.FindingsFrom 31,393 citations, 133 publications describing 134 unique studies (26 SRs, 36 RCTs, 72 NRSs) were included. Medical cannabis had inconsistent therapeutic effects in specific patient conditions (e.g., end-stage cancer, dementia), with a number of studies suggesting possible benefits while others found no benefit. For medical cannabis, harmful associations outnumbered beneficial, and RCTs reported more negative effects than NRSs. Cannabis use was associated with greater frequencies of depression, anxiety, cognitive impairment, substance use and problematic substance use, accidents/injuries, and acute healthcare use. Studies often were small, did not consistently assess harms, and did not adjust for confounding.DiscussionThe effects of medical cannabis are inconsistent within specific patient conditions. For older adults, generally, the available evidence suggests cannabis use may be associated with greater frequencies of mental health issues, substance use, and acute healthcare use, and the benefit-to-risk ratio is unclear. Studies with a balanced assessment of benefits and harms may guide appropriate public health messaging to balance the marketing pressures of cannabis to older adults.